Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. It is not yet known whether sulindac, aspirin, or
ursodiol is more effective in preventing colorectal cancer.
PURPOSE: This randomized phase II trial is studying how well sulindac works compared to
aspirin or ursodiol in preventing colorectal cancer.